Literature DB >> 10049665

Pericardial fluid absorption into lymphatic vessels in sheep.

B Boulanger1, Z Yuan, M Flessner, J Hay, M Johnston.   

Abstract

We estimated the volumetric lymphatic clearance rate of pericardial fluid in sheep. In the first group of studies, 125I-human serum albumin (HSA) was injected into the pericardial cavity and after 4 h, various lymph nodes and tissues were excised and counted for radioactivity. Several lymphatic drainage pathways existed defined by elevated 125I-HSA in the middle and caudal mediastinal, intercostal, and the cardiac nodes located near the root of the aorta. In a second group of experiments, the plasma recovery of intrapericardially administered tracer was compared in sheep with intact lymphatics and in animals in which thoracic duct lymph was diverted and other relevant lymphatics ligated. The 4-h plasma recoveries were reduced significantly from an average of 12.2 +/- 3. 4% injected dose in the lymph-intact group to 3.0 +/- 1.1% injected dose in the diverted/ligated group (an inhibition of approximately 75%). In order to estimate the volumetric clearance of pericardial fluid through lymphatics in conscious sheep, 125I-HSA was administered into the pericardial cavity to serve as the lymph flow marker. 131I-HSA was injected intravenously to permit calculation of plasma tracer loss and tracer recirculation into lymphatics. From mass balance equations, total pericardial clearance into lymphatics averaged 1.50 +/- 0.43 ml/h or approximately 1.13 ml/h if one was to assume that the average 25% recovered plasma tracer in lymph diverted/ligated animals was due to nonlymphatic transport. In conclusion, mediastinal lymphatic pathways remove a volume equivalent to the pericardial volume (8.1 +/- 1.1 ml) every 5.4 to 7. 2 h. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10049665     DOI: 10.1006/mvre.1998.2127

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  10 in total

1.  Delivery of gelfoam-enabled cells and vectors into the pericardial space using a percutaneous approach in a porcine model.

Authors:  D Ladage; I C Turnbull; K Ishikawa; Y Takewa; K Rapti; C Morel; I Karakikes; L Hadri; J Müller-Ehmsen; K D Costa; R J Hajjar; Y Kawase
Journal:  Gene Ther       Date:  2011-04-21       Impact factor: 5.250

Review 2.  Right side of heart failure.

Authors:  Maya Guglin; Sameer Verma
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

3.  Potential of gene therapy as a treatment for heart failure.

Authors:  Roger J Hajjar
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

4.  Nanoparticles administered intrapericardially enhance payload myocardial distribution and retention.

Authors:  Victor Segura-Ibarra; Francisca E Cara; Suhong Wu; David A Iruegas-Nunez; Sufen Wang; Mauro Ferrari; Arturas Ziemys; Miguel Valderrabano; Elvin Blanco
Journal:  J Control Release       Date:  2017-07-09       Impact factor: 9.776

5.  A case of diminished pericardial effusion after treatment of a giant hepatic cyst.

Authors:  Hiroshi Okano; Tomomasa Tochio; Hiroaki Kumazawa; Yoshiaki Isono; Hiroki Tanaka; Shimpei Matsusaki; Tomohiro Sase; Tomonori Saito; Katsumi Mukai; Akira Nishimura; Tetsuya Kitamura; Takuya Mori
Journal:  Clin J Gastroenterol       Date:  2017-05-18

Review 6.  Gene therapy for heart failure: where do we stand?

Authors:  Charbel Naim; Armen Yerevanian; Roger J Hajjar
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

Review 7.  Physiology of pericardial fluid production and drainage.

Authors:  Konstantinos Vogiatzidis; Sotirios G Zarogiannis; Isaac Aidonidis; Evgeniy I Solenov; Paschalis-Adam Molyvdas; Konstantinos I Gourgoulianis; Chrissi Hatzoglou
Journal:  Front Physiol       Date:  2015-03-18       Impact factor: 4.566

8.  Different Expressions of Pericardial Fluid MicroRNAs in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy and Ischemic Heart Disease Undergoing Ventricular Tachycardia Ablation.

Authors:  Aleksandr A Khudiakov; Daniil D Panshin; Yulia V Fomicheva; Anastasia A Knyazeva; Ksenia A Simonova; Dmitry S Lebedev; Evgeny N Mikhaylov; Anna A Kostareva
Journal:  Front Cardiovasc Med       Date:  2021-03-19

9.  Therapeutic payload delivery to the myocardium: Evolving strategies and obstacles.

Authors:  Tarek Shazly; Arianna Smith; Mark J Uline; Francis G Spinale
Journal:  JTCVS Open       Date:  2022-05-05

10.  Malignant Pleural Mesothelioma presenting with Cardiac Tamponade- A Rare Case report and Review of the literature.

Authors:  Apoorva Jayaranagaiah; Pramod Theetha Kariyanna; Naga Koteshwari Sucharitra Chidella; Navneet Singh; Jason Green; Moro O Salifu; Samy I McFarlane
Journal:  Clin Case Rep Rev       Date:  2018-05-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.